Related Experiment Video

Updated: Jun 24, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

[Infantile tuberculosis--to be considered again]

Pia Toikka1, Merja Helminen, Iiris Rajalahti

  • 1TAYS:n lastenklinikka, PL 2000, 33521 Tampere.

Duodecim; Laaketieteellinen Aikakauskirja
|April 4, 2009
PubMed

Insights

Finland stopped routine BCG newborn vaccination in 2006. A six-month-old infant developed tuberculosis despite not being in a risk group, highlighting potential gaps in targeted vaccination strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Finland transitioned from universal newborn Bacillus Calmette-Guérin (BCG) vaccination to a targeted approach in August 2006.
  • The current strategy prioritizes BCG vaccination for children identified as having an increased risk of tuberculosis (TB) exposure.

Observation:

  • A six-month-old Finnish infant was diagnosed with pulmonary tuberculosis.
  • The infant did not belong to any recognized risk group and had not received the BCG vaccine as a newborn.

Findings:

  • Despite extensive investigations, the source of the infant's tuberculosis infection could not be identified.
  • This case represents a potential gap in the current targeted BCG vaccination policy.

Implications:

  • The findings suggest that targeted BCG vaccination may not fully capture all infants at risk for TB.
  • Further evaluation of TB transmission dynamics in young children and the effectiveness of current risk stratification is warranted.
  • This case underscores the importance of considering TB in unvaccinated infants, even in low-prevalence settings.

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...